PharmaBoardroom

The bright future of mRNA technology – InConversation…

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

Ashish D Pal – Managing Director, MSD Singapore, Malaysia…

MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the importance of leveraging learnings…

The Collaborative Spirit of Cell & Gene

One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they are not just technologically…

5 US Rare Disease Start-Ups to Watch

Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan therapies in Europe, here we move to…

HiFiBiO CEO on the Keys to Global Biotech Success

HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…

Harjit Gill – CEO, APACMed

In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a…

After Brexit: Focus on the New Pharmaceutical Strategy for Europe

Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the future of European pharma post-Brexit,…

New Drug Approvals in China in 2020

Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi Wang from the Shanghai Center for…

Russia: $7.4 bln for Healthcare Modernisation; Generics Push;…

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…

The Long Read / Norway: Unlocking Potential

Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…

Vaccines: Manufacturing & Supply Chain Complexity

Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…

Building a Health Data Ecosystem in Switzerland

Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one potential stumbling block is access to and…

Tagged with